Stock Earnings

Question 1

Quels sont les états financiers clés de Mirum Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Mirum Pharmaceuticals Inc a un total d'actifs de $670, un bénéfice net loss de $-87

Question 2

Quels sont les ratios financiers clés pour MIRM ?

Accepted Answer

Le ratio de liquidité de Mirum Pharmaceuticals Inc est 1.5, la marge nette est -25.89, les ventes par action sont de $7.07.

Question 3

Comment les revenus de Mirum Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Mirum Pharmaceuticals Inc largest revenue segment is Pharmaceutical, at a revenue of 336,409,000 in the most earnings release.For geography, United States is the primary market for Mirum Pharmaceuticals Inc, at a revenue of 274,173,000.

Question 4

Mirum Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Mirum Pharmaceuticals Inc a un bénéfice net loss de $-87

Question 5

Mirum Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

yes, Mirum Pharmaceuticals Inc a un passif de 445

Question 6

Combien d'actions en circulation Mirum Pharmaceuticals Inc a-t-elle ?

Accepted Answer

Mirum Pharmaceuticals Inc a un total d'actions en circulation de 48.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	471	336	186	77	19	0
Revenue Growth (YoY)	53%	81%	142%	305%	--	--
Cost of Revenue	94	81	47	12	1	--
Gross Profit	377	255	139	64	17	--
Selling, General & Admin	239	202	145	89	59	22
Research & Development	179	140	102	106	131	81
Operating Expenses	418	342	248	195	190	104
Other Non Operating Income (Expenses)	2	1	-2	0	0	0
Pretax Income	-40	-86	-162	-142	-83	-103
Income Tax Expense	0	1	0	-6	0	0
Net Income	-41	-87	-163	-135	-83	-103
Net Income Growth	-59%	-47%	21%	63%	-19%	98%
Shares Outstanding (Diluted)	56.99	47.52	40.88	33.84	30.32	25.25
Shares Change (YoY)	19%	16%	21%	12%	20%	10%
EPS (Diluted)	-0.73	-1.85	-3.99	-4.01	-2.77	-4.09
EPS Growth	-65%	-54%	0%	45%	-32%	79%
Free Cash Flow	44	-10	-91	-120	-151	-89
Free Cash Flow Per Share	0.77	-0.21	-2.22	-3.54	-4.98	-3.52
Gross Margin	80.04%	75.89%	74.73%	83.11%	89.47%	--
Operating Margin	-8.7%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Profit Margin	-8.7%	-25.89%	-87.63%	-175.32%	-436.84%	0%
Free Cash Flow Margin	9.34%	-2.97%	-48.92%	-155.84%	-794.73%	0%
EBITDA	-17	-64	-99	-128	-173	-104
EBITDA Margin	-3.6%	-19.04%	-53.22%	-166.23%	-910.52%	0%
D&A For EBITDA	24	23	10	3	0	0
EBIT	-41	-87	-109	-131	-173	-104
EBIT Margin	-8.7%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Effective Tax Rate	0%	-1.16%	0%	4.22%	0%	0%

Mirum Pharmaceuticals Inc (MIRM) Price

MIRM Stock Price Chart

MIRM Income

Follow-Up Questions